Genetic Relationship between Schizophrenia and Nicotine Dependence.
paper
Cited
Public
- Authors
- Chen, Jingchun; Bacanu, Silviu-Alin; Yu, Hui; Zhao, Zhongming; Jia, Peilin; Kendler, Kenneth S; Kranzler, Henry R; Gelernter, Joel; Farrer, Lindsay; Minica, Camelia; Pool, Rene; Milaneschi, Yuri; Boomsma, Dorret I; Penninx, Brenda W J H; Tyndale, Rachel F; Ware, Jennifer J; Vink, Jacqueline M; Kaprio, Jaakko; MunafΓ², Marcus; Chen, Xiangning; Cotinine meta-analysis group; FTND meta-analysis group
- Year
- 2016
- Journal
- Scientific reports
- PMID
- 27164557
- DOI
- 10.1038/srep25671
- PMCID
- PMC4862382
It is well known that most schizophrenia patients smoke cigarettes. There are different hypotheses postulating the underlying mechanisms of this comorbidity. We used summary statistics from large meta-analyses of plasma cotinine concentration (COT), FagerstrΓΆm test for nicotine dependence (FTND) and schizophrenia to examine the genetic relationship between these traits. We found that schizophrenia risk scores calculated at P-value thresholds of 5βΓβ10(-3) and larger predicted FTND and cigarettes smoked per day (CPD), suggesting that genes most significantly associated with schizophrenia were not associated with FTND/CPD, consistent with the self-medication hypothesis. The COT risk scores predicted schizophrenia diagnosis at P-values of 5βΓβ10(-3) and smaller, implying that genes most significantly associated with COT were associated with schizophrenia. These results implicated that schizophrenia and FTND/CPD/COT shared some genetic liability. Based on this shared liability, we identified multiple long non-coding RNAs and RNA binding protein genes (DA376252, BX089737, LOC101927273, LINC01029, LOC101928622, HY157071, DA902558, RBFOX1 and TINCR), protein modification genes (MANBA, UBE2D3, and RANGAP1) and energy production genes (XYLB, MTRF1 and ENOX1) that were associated with both conditions. Further analyses revealed that these shared genes were enriched in calcium signaling, long-term potentiation and neuroactive ligand-receptor interaction pathways that played a critical role in cognitive functions and neuronal plasticity.
Pathway crosstalk network.The size of the node is proportional to the P-values of pathway enrichment test. The thickness of the edge is proportional to the P-values of pathway crosstalk.
| # | Section | Preview |
|---|---|---|
| 20 | Methods β Identification of shared risk genes | While there are papers looking at pleiotropy from a conditional FDR point of view71, we arrive toβ¦ |
| 21 | Methods β Identification of shared risk genes | are independent, the P-value (also denoted as overlap P-value) for a given overlap statistic, r, atβ¦ |
| 22 | Methods β Identification of shared risk genes | (1), under the worst case scenario of an extreme signal in one phenotype, the false positive rateβ¦ |
| 23 | Methods β Pathway and network analyses | We conducted pathway enrichment analysis of genes with at least one marker with q-values lower thanβ¦ |
| 24 | Methods β Pathway and network analyses | We further examined pathways interaction using the Characteristic Sub-Pathway Network (CSPN)β¦ |
| 25 | Additional Information | How to cite this article: Chen, J. et al. Genetic relationship between schizophrenia and nicotine⦠|
β Prev
21β26 of 26
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
| Citation | PMID | DOI | Status |
|---|---|---|---|
| AkarsuS. et al. Mitochondrial complex I and III gene mRNA levels in schizophrenia, and their relationship with clinical features. J. Mol. Psychiatry 2, 6 (2014).2571372310.1186/s40303-014-0006-9PMC4307627 | β | β | β |
| AndreassenO. A. et al. Improved detection of common variants associated with schizophrenia and bipolar disorder using pleiotropy-informed conditional false discovery rate. PLoS Genet. 9, e1003455 (2013).2363762510.1371/journal.pgen.1003455PMC3636100 | β | β | β |
| AndreassenO. A. et al. Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors. Am. J. Hum. Genet. 92, 197β209 (2013).2337565810.1016/j.ajhg.2013.01.001PMC3567279 | β | β | β |
| AndreassenO. A., ThompsonW. K. & DaleA. M. Boosting the power of schizophrenia genetics by leveraging new statistical tools. Schizophr. Bull. 40, 13β17 (2014).2431911810.1093/schbul/sbt168PMC3885310 | β | β | β |
| AshareR. L., FalconeM. & LermanC. Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment. Neuropharmacology 76 Pt B, 581β591 (2014).2363943710.1016/j.neuropharm.2013.04.034PMC3779499 | β | β | β |
| AyalewM. et al. Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Mol. Psychiatry 17, 887β905 (2012).2258486710.1038/mp.2012.37PMC3427857 | β | β | β |
| BarciaG. et al. De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. Nat. Genet. 44, 1255β1259 (2012).2308639710.1038/ng.2441PMC3687547 | β | β | β |
| BarryG. et al. The long non-coding RNA Gomafu is acutely regulated in response to neuronal activation and involved in schizophrenia-associated alternative splicing. Mol. Psychiatry 19, 486β494 (2014).2362898910.1038/mp.2013.45 | β | β | β |
| BarryG. Integrating the roles of long and small non-coding RNA in brain function and disease. Mol. Psychiatry 19, 410β416 (2014).2446882310.1038/mp.2013.196 | β | β | β |
| BenjaminiY. & HochbergY. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J. R. Stat. Soc. Ser. B Methodol. 57, 289β300 (1995). | β | β | β |
| BenjaminiY. & YekutieliD. Quantitative trait Loci analysis using the false discovery rate. Genetics 171, 783β790 (2005).1595667410.1534/genetics.104.036699PMC1456787 | β | β | β |
| BenowitzN. L., DainsK. M., DempseyD., YuL. & JacobP. Estimation of nicotine dose after low-level exposure using plasma and urine nicotine metabolites. Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol. 19, 1160β1166 (2010).10.1158/1055-9965.EPI-09-1303PMC286707520447913 | β | β | β |
| BierutL. J. et al. Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum. Mol. Genet. 16, 24β35 (2007).1715818810.1093/hmg/ddl441PMC2278047 | β | β | β |
| BigdeliT. B. et al. On schizophrenia as a βdisease of humanityβ. Schizophr. Res. 143, 223β224 (2013).2318244010.1016/j.schres.2012.10.036PMC3556386 | β | β | β |
| BΓ©nitP. et al. Mutant NDUFV2 subunit of mitochondrial complex I causes early onset hypertrophic cardiomyopathy and encephalopathy. Hum. Mutat. 21, 582β586 (2003).1275470310.1002/humu.10225 | β | β | β |
| ChenX. et al. GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia. Mol. Psychiatry 16, 1117β1129 (2011).2083839610.1038/mp.2010.96PMC3443634 | β | β | β |
| Davey SmithG. & HemaniG. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum. Mol. Genet. 23, R89β98 (2014).2506437310.1093/hmg/ddu328PMC4170722 | β | β | β |
| DaviesG. et al. Genome-wide association studies establish that human intelligence is highly heritable and polygenic. Mol. Psychiatry 16, 996β1005 (2011).2182606110.1038/mp.2011.85PMC3182557 | β | β | β |
| de LeonJ. & DiazF. J. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr. Res. 76, 135β157 (2005).1594964810.1016/j.schres.2005.02.010 | β | β | β |
| de LeonJ. & DiazF. J. Genetics of schizophrenia and smoking: an approach to studying their comorbidity based on epidemiological findings. Hum. Genet. 131, 877β901 (2012).2219015310.1007/s00439-011-1122-6PMC3536540 | β | β | β |
| De LucaV. et al. Evidence of association between smoking and alpha7 nicotinic receptor subunit gene in schizophrenia patients. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 29, 1522β1526 (2004).10.1038/sj.npp.130046615100704 | β | β | β |
| FanY. et al. Focal adhesion dynamics are altered in schizophrenia. Biol. Psychiatry 74, 418β426 (2013).2348224610.1016/j.biopsych.2013.01.020 | β | β | β |
| FΓΆckingM. et al. Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia. Mol. Psychiatry 20, 424β432 (2015).2504800410.1038/mp.2014.63 | β | β | β |
| HallF. S. et al. Negative affective states and cognitive impairments in nicotine dependence. Neurosci. Biobehav. Rev. 58, 168β185 (2015).2605479010.1016/j.neubiorev.2015.06.004PMC4670824 | β | β | β |
| HallJ., TrentS., ThomasK. L., OβDonovanM. C. & OwenM. J. Genetic risk for schizophrenia: convergence on synaptic pathways involved in plasticity. Biol. Psychiatry 77, 52β58 (2015).2515243410.1016/j.biopsych.2014.07.011 | β | β | β |
| HanG., AnL., YangB., SiL. & ZhangT. Nicotine-induced impairments of spatial cognition and long-term potentiation in adolescent male rats. Hum. Exp. Toxicol. 33, 203β213 (2014).2383684010.1177/0960327113494902 | β | β | β |
| HeathertonT. F., KozlowskiL. T., FreckerR. C. & FagerstrΓΆmK. O. The FagerstrΓΆm Test for Nicotine Dependence: a revision of the FagerstrΓΆm Tolerance Questionnaire. Br. J. Addict. 86, 1119β1127 (1991).193288310.1111/j.1360-0443.1991.tb01879.x | β | β | β |
| HishimotoA. et al. Neurexin 3 polymorphisms are associated with alcohol dependence and altered expression of specific isoforms. Hum. Mol. Genet. 16, 2880β2891 (2007).1780442310.1093/hmg/ddm247 | β | β | β |
| HolmansP. et al. Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. Am. J. Hum. Genet. 85, 13β24 (2009).1953988710.1016/j.ajhg.2009.05.011PMC2706963 | β | β | β |
| HongL. E. et al. A CHRNA5 allele related to nicotine addiction and schizophrenia. Genes Brain Behav. 10, 530β535 (2011).2141814010.1111/j.1601-183X.2011.00689.xPMC3126887 | β | β | β |
| HuangY. & LiS. Detection of characteristic sub pathway network for angiogenesis based on the comprehensive pathway network. BMC Bioinformatics 11 Suppl 1, S32 (2010).2012220510.1186/1471-2105-11-S1-S32PMC3009504 | β | β | β |
| International Schizophrenia Consortium . Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748β752 (2009).1957181110.1038/nature08185PMC3912837 | β | β | β |
| JacksonK. J., FanousA. H., ChenJ., KendlerK. S. & ChenX. Variants in the 15q25 gene cluster are associated with risk for schizophrenia and bipolar disorder. Psychiatr. Genet. 23, 20β28 (2013).2319687510.1097/YPG.0b013e32835bd5f1PMC3644701 | β | β | β |
| JenkinsA. K. et al. Neurexin 1 (NRXN1) splice isoform expression during human neocortical development and aging. Mol. Psychiatry, 10.1038/mp.2015.107 (2015).PMC473131626216298 | β | β | β |
| JiaP. et al. A bias-reducing pathway enrichment analysis of genome-wide association data confirmed association of the MHC region with schizophrenia. J. Med. Genet. 49, 96β103 (2012).2218749510.1136/jmedgenet-2011-100397 | β | β | β |
| JiaP., WangL., MeltzerH. Y. & ZhaoZ. Common variants conferring risk of schizophrenia: a pathway analysis of GWAS data. Schizophr. Res. 122, 38β42 (2010).2065978910.1016/j.schres.2010.07.001PMC2933424 | β | β | β |
| JiaY., YamazakiY., NakauchiS., ItoK.-I. & SumikawaK. Nicotine facilitates long-term potentiation induction in oriens-lacunosum moleculare cells via Ca2+ entry through non-alpha7 nicotinic acetylcholine receptors. Eur. J. Neurosci. 31, 463β476 (2010).2011334410.1111/j.1460-9568.2009.07058.xPMC2852628 | β | β | β |
| KathiresanS. et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat. Genet. 41, 56β65 (2009).1906090610.1038/ng.291PMC2881676 | β | β | β |
| KumariV. & PostmaP. Nicotine use in schizophrenia: the self medication hypotheses. Neurosci. Biobehav. Rev. 29, 1021β1034 (2005).1596407310.1016/j.neubiorev.2005.02.006 | β | β | β |
| KutluM. G. & GouldT. J. Nicotinic modulation of hippocampal cell signaling and associated effects on learning and memory. Physiol. Behav. 155, 162β171 (2016).2668789510.1016/j.physbeh.2015.12.008PMC4718748 | β | β | β |
| LalD. et al. RBFOX1 and RBFOX3 mutations in rolandic epilepsy. PloS One 8, e73323 (2013).2403990810.1371/journal.pone.0073323PMC3765197 | β | β | β |
| LionelA. C. et al. Rare exonic deletions implicate the synaptic organizer Gephyrin (GPHN) in risk for autism, schizophrenia and seizures. Hum. Mol. Genet. 22, 2055β2066 (2013).2339315710.1093/hmg/ddt056 | β | β | β |
| LiuH.-Y., LiaoP.-C., ChuangK.-T. & KaoM.-C. Mitochondrial targeting of human NADH dehydrogenase (ubiquinone) flavoprotein 2 (NDUFV2) and its association with early-onset hypertrophic cardiomyopathy and encephalopathy. J. Biomed. Sci. 18, 29 (2011).2154892110.1186/1423-0127-18-29PMC3117770 | β | β | β |
| LoukolaA. et al. Genome-wide association study on detailed profiles of smoking behavior and nicotine dependence in a twin sample. Mol. Psychiatry 19, 615β624 (2014).2375224710.1038/mp.2013.72PMC3883996 | β | β | β |
| LuckW. & NauH. Nicotine and cotinine concentrations in serum and milk of nursing smokers. Br. J. Clin. Pharmacol. 18, 9β15 (1984).674349210.1111/j.1365-2125.1984.tb05014.xPMC1463577 | β | β | β |
| MalaiyandiV., GoodzS. D., SellersE. M. & TyndaleR. F. CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smoking. Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol. 15, 1812β1819 (2006).10.1158/1055-9965.EPI-05-072317035386 | β | β | β |
| NovakG. et al. Association of polymorphisms in the BDNF, DRD1 and DRD3 genes with tobacco smoking in schizophrenia. Ann. Hum. Genet. 74, 291β298 (2010).2045631910.1111/j.1469-1809.2010.00578.x | β | β | β |
| NovakG., BoukhadraJ., ShaikhS. A., KennedyJ. L. & Le FollB. Association of a polymorphism in the NRXN3 gene with the degree of smoking in schizophrenia: a preliminary study. World J. Biol. Psychiatry Off. J. World Fed. Soc. Biol. Psychiatry 10, 929β935 (2009).10.1080/1562297090307949919658047 | β | β | β |
| NussbaumJ. et al. Significant association of the neurexin-1 gene (NRXN1) with nicotine dependence in European- and African-American smokers. Hum. Mol. Genet. 17, 1569β1577 (2008).1827020810.1093/hmg/ddn044PMC2902291 | β | β | β |
| PurcellS. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559β575 (2007).1770190110.1086/519795PMC1950838 | β | β | β |
| PurcellS. M. et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506, 185β190 (2014).2446350810.1038/nature12975PMC4136494 | β | β | β |
| ReisigerA.-R. et al. Nicotine self-administration induces CB1-dependent LTP in the bed nucleus of the stria terminalis. J. Neurosci. Off. J. Soc. Neurosci. 34, 4285β4292 (2014).10.1523/JNEUROSCI.3149-13.2014PMC660809424647948 | β | β | β |
| RipkeS. et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat. Genet. 45, 1150β1159 (2013).2397487210.1038/ng.2742PMC3827979 | β | β | β |
| SacconeS. F. et al. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum. Mol. Genet. 16, 36β49 (2007).1713527810.1093/hmg/ddl438PMC2270437 | β | β | β |
| SalavatiB. et al. Imaging-based neurochemistry in schizophrenia: a systematic review and implications for dysfunctional long-term potentiation. Schizophr. Bull. 41, 44β56 (2015).2524965410.1093/schbul/sbu132PMC4266301 | β | β | β |
| Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium. Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 43, 969β976 (2011).2192697410.1038/ng.940PMC3303194 | β | β | β |
| Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421β427 (2014).2505606110.1038/nature13595PMC4112379 | β | β | β |
| SivakumaranS. et al. Abundant pleiotropy in human complex diseases and traits. Am. J. Hum. Genet. 89, 607β618 (2011).2207797010.1016/j.ajhg.2011.10.004PMC3213397 | β | β | β |
| SolovieffN., CotsapasC., LeeP. H., PurcellS. M. & SmollerJ. W. Pleiotropy in complex traits: challenges and strategies. Nat. Rev. Genet. 14, 483β495 (2013).2375279710.1038/nrg3461PMC4104202 | β | β | β |
| StephensS. H. et al. Association of the 5β²-upstream regulatory region of the alpha7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia. Schizophr. Res. 109, 102β112 (2009).1918148410.1016/j.schres.2008.12.017PMC2748327 | β | β | β |
| TaoH. et al. Mutations in prickle orthologs cause seizures in flies, mice, and humans. Am. J. Hum. Genet. 88, 138β149 (2011).2127694710.1016/j.ajhg.2010.12.012PMC3035715 | β | β | β |
| ThorgeirssonT. E. et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452, 638β642 (2008).1838573910.1038/nature06846PMC4539558 | β | β | β |
| ThorgeirssonT. E. et al. Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat. Genet. 42, 448β453 (2010).2041888810.1038/ng.573PMC3080600 | β | β | β |
| TimofeevaO. A. & LevinE. D. Glutamate and nicotinic receptor interactions in working memory: importance for the cognitive impairment of schizophrenia. Neuroscience 195, 21β36 (2011).2188476210.1016/j.neuroscience.2011.08.038 | β | β | β |
| Tobacco and Genetics Consortium. Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat. Genet. 42, 441β447 (2010).2041889010.1038/ng.571PMC2914600 | β | β | β |
| TodarelloG. et al. Incomplete penetrance of NRXN1 deletions in families with schizophrenia. Schizophr. Res. 155, 1β7 (2014).2468003110.1016/j.schres.2014.02.023 | β | β | β |
| WangJ. & LiM. D. Common and Unique Biological Pathways Associated with Smoking Initiation/Progression, Nicotine Dependence, and Smoking Cessation. Neuropsychopharmacology 35, 702β719 (2010).1989025910.1038/npp.2009.178PMC2814000 | β | β | β |
| WareJ. J. et al. Genome-Wide Meta-Analysis of Cotinine Levels in Cigarette Smokers Identifies Locus at 4q13.2. Sci. Rep. 6, 20092 (2016).2683318210.1038/srep20092PMC4735517 | β | β | β |
| WashizukaS. et al. Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with schizophrenia in the Japanese population. Am. J. Med. Genet. Part B Neuropsychiatr. Genet. Off. Publ. Int. Soc. Psychiatr. Genet. 141B, 301β304 (2006).10.1002/ajmg.b.3028516508936 | β | β | β |
| WeiserM. et al. Higher rates of cigarette smoking in male adolescents before the onset of schizophrenia: a historical-prospective cohort study. Am. J. Psychiatry 161, 1219β1223 (2004).1522905410.1176/appi.ajp.161.7.1219 | β | β | β |
| WuJ. et al. Integrated network analysis platform for protein-protein interactions. Nat. Methods 6, 75β77 (2009).1907925510.1038/nmeth.1282 | β | β | β |
| ZhangB., KirovS. & SnoddyJ. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res. 33, W741β748 (2005).1598057510.1093/nar/gki475PMC1160236 | β | β | β |
| ZhangX. Y. et al. Association of functional dopamine-beta-hydroxylase (DBH) 19 bp insertion/deletion polymorphism with smoking severity in male schizophrenic smokers. Schizophr. Res. 141, 48β53 (2012).2287134510.1016/j.schres.2012.07.011 | β | β | β |
| ZhaoZ. et al. Transcriptome sequencing and genome-wide association analyses reveal lysosomal function and actin cytoskeleton remodeling in schizophrenia and bipolar disorder. Mol. Psychiatry 20, 563β572 (2015).2511337710.1038/mp.2014.82PMC4326626 | β | β | β |
| ZhernakovaA., van DiemenC. C. & WijmengaC. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat. Rev. Genet. 10, 43β55 (2009).1909283510.1038/nrg2489 | β | β | β |
| ZiedonisD. et al. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine Tob. Res. Off. J. Soc. Res. Nicotine Tob. 10, 1691β1715 (2008).10.1080/1462220080244356919023823 | β | β | β |
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Genetic correlation between smoking behaviors and schizophrenia. | 2018 | 28285025 |
| Association Between Substance Use Disorder and Polygenic Liability to Schizophrenia. | 2017 | 28739213 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| The Effect of Smoking Cigarettes on the Progression of Psychotic Experiences to Psychotic Disorder: Evidence From a 6-Year Follow-Up Study. | GΓΌvercin E et al. | β | 2026 | β |
| A multi-level exploration of the genetic basis between lung cancer and schizophrenia. | Wu L et al. | β | 2025 | β |
| Genetics of constant and severe pain in the NAPS2 cohort of recurrent acute and chronic pancreatitis patients. | Dunbar EK et al. | β | 2025 | β |
| The Causal Relationship Between Gut Microbiomes, Inflammatory Mediators, and Traumatic Brain Injury in Europeans: Evidence from Genetic Correlation and Functional Mapping Annotation Analyses. | Song B et al. | β | 2025 | β |
| Transcriptomic Analysis of the Human Habenula in Schizophrenia. | Yalcinbas EA et al. | β | 2025 | β |
| Combining neuroimaging and brain stimulation to test alternative causal pathways for nicotine addiction in schizophrenia. | Du X et al. | β | 2024 | β |
| Establishing associated risk factors, including fungal and parasitic infections among Malaysians living with schizophrenia. | Franklin F et al. | β | 2024 | β |
| Exploring the shared genetic basis of major depressive disorder and frailty. | Fu W et al. | β | 2024 | β |
| The effects of noise exposure on hippocampal cognition in C57BL/6 mice via transcriptomics. | Zhou Z et al. | β | 2024 | β |
| Tract-based analyses of white matter in schizophrenia, bipolar disorder, aging, and dementia using high spatial and directional resolution diffusion imaging: a pilot study. | Mamah D et al. | β | 2024 | β |
| Adverse perinatal pregnancy outcomes in women with schizophrenia: A systematic review and meta-analysis. | Tang W et al. | β | 2023 | β |
| Associations between genetic liabilities to smoking behavior and schizophrenia symptoms in patients with a psychotic disorder, their siblings and healthy controls. | Lin BD et al. | β | 2023 | β |
| Impaired extinction of operant cocaine in a genetic mouse model of schizophrenia risk. | Chesworth R et al. | β | 2023 | β |
| Patients with schizophrenia and bipolar disorder display a similar global gene expression signature in whole blood that reflects elevated proportion of immature neutrophil cells with association to lipid changes. | Torsvik A et al. | β | 2023 | β |
| Prevalence of tobacco smoking in people at clinical high-risk for psychosis: Systematic review and meta-analysis. | De Micheli A et al. | β | 2023 | β |
| The shared genetic architecture of smoking behaviours and psychiatric disorders: evidence from a population-based longitudinal study in England. | Ajnakina O et al. | β | 2023 | β |
| Evaluation of the causal relationship between smoking and schizophrenia in East Asia. | Su MH et al. | β | 2022 | β |
| Impact of Nicotine on Cognition in Patients With Schizophrenia: A Narrative Review. | Spasova V et al. | β | 2022 | β |
| A comprehensive gene-centric pleiotropic association analysis for 14 psychiatric disorders with GWAS summary statistics. | Lu H et al. | β | 2021 | β |
| A genome-wide association study of interhemispheric theta EEG coherence: implications for neural connectivity and alcohol use behavior. | Meyers JL et al. | β | 2021 | β |
| Exploring the Contribution to ADHD of Genes Involved in Mendelian Disorders Presenting with Hyperactivity and/or Inattention. | FernΓ ndez-Castillo N et al. | β | 2021 | β |
| Genome-wide analyses of smoking behaviors in schizophrenia: Findings from the Psychiatric Genomics Consortium. | Peterson RE et al. | β | 2021 | β |
| Identifying risk factors involved in the common versus specific liabilities to substance use: A genetically informed approach. | Iob E et al. | β | 2021 | β |
| Rewired Pathways and Disrupted Pathway Crosstalk in Schizophrenia Transcriptomes by Multiple Differential Coexpression Methods. | Yu H et al. | β | 2021 | β |
| The Association between Lifestyle Choices and Schizophrenia Symptoms. | Kalinowska S et al. | β | 2021 | β |
| Association between polygenic liability for schizophrenia and substance involvement: A nationwide population-based study in Taiwan. | Wang SH et al. | β | 2020 | β |
| Expression correlation attenuates within and between key signaling pathways in chronic kidney disease. | Yu H et al. | β | 2020 | β |
| Genome-Wide Meta-Analyses of FTND and TTFC Phenotypes. | Chen J et al. | β | 2020 | β |
| Identification of 34 genes conferring genetic and pharmacological risk for the comorbidity of schizophrenia and smoking behaviors. | Ma Y et al. | β | 2020 | β |
| Polygenic risk scores for late smoking initiation associated with the risk of schizophrenia. | Ohi K et al. | β | 2020 | β |
| The Effects of Tobacco Smoking, and Prenatal Tobacco Smoke Exposure, on Risk of Schizophrenia: A Systematic Review and Meta-Analysis. | Hunter A et al. | β | 2020 | β |
| Enrichment of Up-regulated and Down-regulated Gene Clusters Using Gene Ontology, miRNAs and lncRNAs in Colorectal Cancer. | Fattahi F et al. | β | 2019 | β |
| Genome-Wide Variants Shared Between Smoking Quantity and Schizophrenia on 15q25 Are Associated With CHRNA5 Expression in the Brain. | Ohi K et al. | β | 2019 | β |
| Nicotine consumption during the prodromal phase of schizophrenia - a review of the literature. | Gogos A et al. | β | 2019 | β |
| Regulatory genes and pathways disrupted in autism spectrum disorders. | Ayhan F et al. | β | 2019 | β |
| Smoking Rates and Number of Cigarettes Smoked per Day in Schizophrenia: A Large Cohort Meta-Analysis in a Japanese Population. | Ohi K et al. | β | 2019 | β |
| The relationship between nicotine and psychosis. | Quigley H et al. | β | 2019 | β |
| Use of tobacco in schizophrenia: A double-edged sword. | Fang Y et al. | β | 2019 | β |
| ANCO-GeneDB: annotations and comprehensive analysis of candidate genes for alcohol, nicotine, cocaine and opioid dependence. | Hu R et al. | β | 2018 | β |
| Cigarette Smoking by Patients With Serious Mental Illness, 1999-2016: An Increasing Disparity. | Dickerson F et al. | β | 2018 | β |
| Evidence of a Causal Relationship Between Smoking Tobacco and Schizophrenia Spectrum Disorders. | Scott JG et al. | β | 2018 | β |
| Genetic correlation between smoking behaviors and schizophrenia. | Hartz SM et al. | β | 2018 | β |
| Genetic Correlation Profile of Schizophrenia Mirrors Epidemiological Results and Suggests Link Between Polygenic and Rare Variant (22q11.2) Cases of Schizophrenia. | Duncan LE et al. | β | 2018 | β |
| Genetic variation in CHRNA7 and CHRFAM7A is associated with nicotine dependence and response to varenicline treatment. | Cameli C et al. | β | 2018 | β |
| Genetic vulnerability to schizophrenia is associated with cannabis use patterns during adolescence. | Hiemstra M et al. | β | 2018 | β |
| Nicotine dependence in Croatian male inpatients with schizophrenia. | Ε agud M et al. | β | 2018 | β |
| Smokin' hot: adolescent smoking and the risk of psychosis. | Mustonen A et al. | β | 2018 | β |
| Temporal trends in cardiovascular disease risk factor profiles in a population-based schizophrenia sample: a repeat cross-sectional study. | Chiu M et al. | β | 2018 | β |
| Tobacco smoking is associated with psychotic experiences in the general population of South London. | Bhavsar V et al. | β | 2018 | β |
| Association between substance use disorder and polygenic liability to schizophrenia | Hartz SM et al. | β | 2017 | β |
| Association Between Substance Use Disorder and Polygenic Liability to Schizophrenia. | Hartz SM et al. | β | 2017 | β |
| Drug enrichment and discovery from schizophrenia genome-wide association results: an analysis and visualisation approach. | Gaspar HA et al. | β | 2017 | β |
| Tobacco addiction in the psychiatric population and in the general population. | Oliveira RM et al. | β | 2017 | β |
| The CHRNA5-A3-B4 Gene Cluster and Smoking: From Discovery to Therapeutics. | Lassi G et al. | β | 2016 | β |